Home › Funds › Parkman Healthcare Partners LLC › URGN
Parkman Healthcare Partners LLC position in URGN
UROGEN PHARMA LTD · Health Care
Parkman Healthcare Partners LLC reported holding 750,202 shares of URGN (UROGEN PHARMA LTD) in its Q3 2026 13F filing — a position valued at US$30.5M, representing 2.75% of its reported portfolio and ranking #8 among its reported holdings. Parkman Healthcare Partners LLC has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's URGN position evolved
Parkman Healthcare Partners LLC first disclosed a stake in URGN in Q3 2023 at 145,311 shares (US$2.0M). The position peaked in Q3 2026 at 750,202 shares, worth US$30.5M. Across 13 filings, Parkman Healthcare Partners LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 750,202 shares valued at US$30.5M — an increase of 576,138 shares quarter over quarter.. Notable position changes include a 128% increase in Q3 2025 (shares rose 17% over the following quarter), a 63% increase in Q1 2026 (shares rose 105% over the following quarter), a 331% increase in Q3 2026 (shares fell 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 145.31K | $2.04M | New |
| Q4 2023 | 175.50K | $2.63M | Add |
| Q1 2024 | 184.18K | $2.76M | Add |
| Q2 2024 | 274.46K | $4.61M | Add |
| Q3 2024 | 347.54K | $4.41M | Add |
| Q4 2024 | 369.86K | $3.94M | Add |
| Q1 2025 | 393.15K | $4.35M | Add |
| Q2 2025 | 176.70K | $2.42M | Reduce |
| Q3 2025 | 402.60K | $8.03M | Add |
| Q4 2025 | 168.77K | $3.95M | Reduce |
| Q1 2026 | 275.00K | $4.94M | Add |
| Q2 2026 | 174.06K | $6.41M | Reduce |
| Q3 2026 | 750.20K | $30.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About URGN and 13F data
URGN (UROGEN PHARMA LTD) is a Health Care company. 46 other funds we track also report a position in URGN — the largest reported positions include RTW INVESTMENTS, LP (US$184.6M), Kynam Capital Management, LP (US$98.9M), Jefferies Financial Group Inc. (US$89.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding URGN
- RTW INVESTMENTS, LP 4.54M sh · $184.62M · Q3 2026
- Kynam Capital Management, LP 2.43M sh · $98.90M · Q3 2026
- Jefferies Financial Group Inc. 2.20M sh · $89.37M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 1.65M sh · $66.98M · Q3 2026
- Opaleye Management Inc. 1.44M sh · $52.99M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.15M sh · $46.67M · Q3 2026
- MPM BioImpact LLC 933.41K sh · $34.35M · Q2 2026
- Soleus Capital Management, L.P. 829.81K sh · $30.54M · Q2 2026
- Boxer Capital Management, LLC 500.00K sh · $18.40M · Q2 2026
- ADAR1 Capital Management, LLC 369.79K sh · $15.02M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 297.08K sh · $12.07M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 184.39K sh · $7.49M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held URGN?
Parkman Healthcare Partners LLC has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in URGN?
As of Q3 2026, Parkman Healthcare Partners LLC holds 750.20K shares of URGN (UROGEN PHARMA LTD), valued at $30.48M, representing 2.75% of its reported portfolio and ranking #8.
Has Parkman Healthcare Partners LLC been buying or selling URGN?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in URGN. The position peaked in Q3 2026 at 750.20K shares.
Which other funds hold URGN?
Other major institutional holders of URGN include RTW INVESTMENTS, LP, Kynam Capital Management, LP, Jefferies Financial Group Inc., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.